Acute and chronic pleural changes after the intrapleural instillation of mitoxantrone in rabbits
- PMID: 9617739
- DOI: 10.1007/pl00007605
Acute and chronic pleural changes after the intrapleural instillation of mitoxantrone in rabbits
Abstract
A previous study demonstrated that the intrapleural injection of 2 mg/kg mitoxantrone in rabbits resulted in a degree of pleurodesis which is comparable to that seen after 35 mg/kg tetracycline but that the animals had a high mortality rate after this dose of mitoxantrone. The objective of the present study was to assess the acute pleural fluid findings, the acute gross and microscopic pleural findings, and the chronic gross and microscopic findings in rabbits that received mitoxantrone. Mitoxantrone, 1.5 mg/kg, was instilled intrapleurally in 70 lightly anesthetized male rabbits. Groups of rabbits were sacrificed 1, 2, 4, 7, 15, 28, and 60 days after the injection. The intrapleural injection of mitoxantrone resulted in an exudative effusion on day 1. The pleural fluid contained predominantly neutrophils and had a mean lactate dehydrogenase (LDH) level that exceeded 4,000 IU/liter. Over the following week the volume of fluid diminished, the predominant cell became the macrophage, and the LDH levels decreased to less than 400 IU/liter. Macroscopic examination of the pleural space revealed that the mean degree of pleurodesis increased progressively over the 60-day observation period. With microscopy, the mean degree of pleural fibrosis also increased progressively. There were also substantial fibrosis and inflammation of the underlying lung and the contralateral lung. The mortality rates were low in the first 28 days (3/70) but subsequently increased and exceeded 80% in the period between 60 and 120 days. This experimental model of pleurodesis should be useful in future studies directed toward uncovering the mechanisms of pleurodesis.
Similar articles
-
Comparison of mitoxantrone and tetracycline as pleural sclerosing agents in rabbits.Lung. 1996;174(6):373-81. doi: 10.1007/BF00164634. Lung. 1996. PMID: 8887932
-
Serial observations after high dose talc slurry in the rabbit model for pleurodesis.Lung. 1998;176(5):299-307. doi: 10.1007/pl00007612. Lung. 1998. PMID: 9685526
-
Temporal evolution of pleural fibrosis induced by intrapleural minocycline injection.Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):791-4. doi: 10.1164/ajrccm.151.3.7881672. Am J Respir Crit Care Med. 1995. PMID: 7881672
-
Management of pleural effusions.J Formos Med Assoc. 2000 Jul;99(7):523-31. J Formos Med Assoc. 2000. PMID: 10925561 Review.
-
Mechanisms of pleurodesis.Respiration. 2012;83(2):91-8. doi: 10.1159/000335419. Epub 2012 Jan 20. Respiration. 2012. PMID: 22286268 Review.
Cited by
-
Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer.BMC Palliat Care. 2004 Sep 9;3(1):4. doi: 10.1186/1472-684X-3-4. BMC Palliat Care. 2004. PMID: 15357871 Free PMC article.
-
A pilot study-is there a role for mitoxantrone pleurodesis in the management of pleural effusion due to lung cancer?Ann Transl Med. 2016 May;4(9):162. doi: 10.21037/atm.2016.04.15. Ann Transl Med. 2016. PMID: 27275475 Free PMC article.
-
Transforming growth factor beta2 induced pleurodesis is not inhibited by corticosteroids.Thorax. 2001 Aug;56(8):643-8. doi: 10.1136/thorax.56.8.643. Thorax. 2001. PMID: 11462068 Free PMC article.
-
Pleurodesis induced by talc or silver nitrate: evaluation of collagen and elastic fibers in pleural remodeling.Lung. 2006 Mar-Apr;184(2):105-11. doi: 10.1007/s00408-005-2569-9. Lung. 2006. PMID: 16622780
-
Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer.World J Surg Oncol. 2004 May 20;2:16. doi: 10.1186/1477-7819-2-16. World J Surg Oncol. 2004. PMID: 15153245 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources